Neramexane is a low-to-moderate affinity uncompetitive NMDA receptor antagonist.
Investigated for use/treatment in alzheimer's disease, hearing loss, and pain (acute or chronic).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.